Cat. No. | Product Name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T18872 | (S,R,S)-AHPC-PEG5-COOH
化合物 T18872
|
2172820-14-1 | 98% |
|
(S,R,S)-AHPC-PEG5-COOH (VH032-PEG5-COOH) is a synthetic E3 ligase ligand-linker conjugate developed for use in PROTAC technology. It consists of the (S,R,S)-AHPC... | ||||
T18824 | Thalidomide-O-C6-NH2 TFA
化合物 T18824
|
1957235-99-2 | 98% |
|
Thalidomide-O-C6-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate used in the PROTAC dTAG-13, a degrader of FKBP12F36V and BET[1]. | ||||
T18817 | Thalidomide-O-amido-C8-NH2 hydrochloride
化合物 T18817
|
T18817 | 98% |
|
Thalidomide-O-amido-C8-NH2 hydrochloride is a synthetic conjugate of an E3 ligase ligand-linker, which combines a cereblon ligand derived from Thalidomide and a ... | ||||
T18812 | Thalidomide-PEG2-C2-NH2 TFA
化合物 T18812
|
2097509-36-7 | 98% |
|
Thalidomide-O-amido-PEG3-C2-NH2 TFA, a synthesized E3 ligase ligand-linker conjugate, combines the cereblon ligand based on Thalidomide and a 2-unit PEG linker f... | ||||
T18671 | (S,R,S)-AHPC-Me-C7 ester
化合物 T18671
|
T18671 | 98% |
|
(S,R,S)-AHPC-Me-C7 ester is a E3 ligase ligand-linker conjugate used to synthesise BCL-XL PROTAC degraders[1]. | ||||
T18669 | (S,R,S)-AHPC-Me-C10-NH2
化合物 T18669
|
2376139-52-3 | 98% |
|
(S,R,S)-AHPC-Me-C10-NH2 is a chemical compound consisting of a synthesized E3 ligase ligand-linker conjugate that incorporates both a VHL ligand and a linker. Th... | ||||
T18666 | (S,R,S)-AHPC-C4-NH2
化合物 T18666
|
2138439-53-7 | 98% |
|
(S,R,S)-AHPC-C4-NH2 is a custom-synthesized conjugate of an E3 ligase ligand-linker, which combines the VHL ligand based on (S,R,S)-AHPC and a linker specificall... | ||||
T18820 | Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride
化合物 T18820
|
2245697-84-9 | 98% |
|
Thalidomide-O-amido-PEG3-C2-NH2 hydrochloride is a chemical compound that has been synthesized as an E3 ligase ligand-linker conjugate. This compound incorporate... | ||||
T18664 | (S,R,S)-AHPC-C3-NH2
化合物 T18664
|
2361119-88-0 | 98% |
|
(S,R,S)-AHPC-C3-NH2 (VH032-C3-NH2) is a synthesized conjugate consisting of an E3 ligase ligand-linker and the VH032 based VHL ligand, which is commonly used in ... | ||||
T18668 | (S,R,S)-AHPC-Me-C10-Br
化合物 T18668
|
T18668 | 98% |
|
(S,R,S)-AHPC-Me-C10-Br is a chemically synthesized conjugate that functions as a ligand-linker for E3 ligases. This compound incorporates a VHL E3 ligase linker ... | ||||
T18806 | Thalidomide-NH-C10-COOH
化合物 T18806
|
T18806 | 98% |
|
Thalidomide-NH-C10-COOH (compound 6b) is a synthetic E3 ligase ligand-linker conjugate. This compound combines the Thalidomide-based von Hippel-Lindau (VHL) liga... | ||||
T13671L | (S,R,S)-AHPC-Me dihydrochloride
化合物 T13671L
|
T13671L | 98% |
|
(S,R,S)-AHPC-Me dihydrochloride, also known as VHL ligand 2 dihydrochloride, is a chemical compound utilized in the synthesis of ARV-771. ARV-771, a BET PROTAC d... | ||||
T18826 | Thalidomide-O-PEG2-propargyl
化合物 T18826
|
2098487-52-4 | 98% |
|
Thalidomide-O-PEG2-propargyl (E3 Ligase Ligand-Linker Conjugates 32) is a chemical compound that has been synthesized as a conjugate of an E3 ligase ligand and a... | ||||
T7752 | (S,R,S)-AHPC-Me
化合物(S,R,S)-AHPC-Me
|
1948273-02-6 | 99.86% |
|
(S,R,S)-AHPC-Me (E3 ligase Ligand 1A) 是基于 (S,R,S)-AHPC 的的 VHL 配体,可用于募集 von Hippel-Lindau (VHL) 蛋白。它可有效降解去势抵抗性前列腺癌细胞中的 BET 蛋白,DC50<1 nM。它可用于合成 ARV-771。 | ||||
T40002 | Pomalidomide-C3-NH2 hydrochloride
化合物Pomalidomide-C3-NH2 hydrochloride
|
2154342-45-5 | 99.60% |
|
Pomalidomide-C3-NH2 hydrochloride 包含基于 Pomalidomide 的 cereblon 配体和 1 个 linker,是合成的 E3 连接酶配体-linker 偶联物,可用于 PROTAC 的合成。 | ||||
T40001 | Pomalidomide-C6-COOH
化合物Pomalidomide-C6-COOH
|
2225940-50-9 | 99.57% |
|
Pomalidomide-C6-COOH 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 CRBN 配体和接头。 | ||||
T5102 | TGN-020
化合物TGN020
|
51987-99-6 | 99.54% |
|
TGN-020 是一种属于 alkyl chain 类的 PROTAC linker,可用于 PROTAC 的合成分子。TGN020 是一种选择性水通道蛋白 4 (AQP4) 抑制剂,IC50为 3.1 μM。TGN020 减轻大鼠脊髓压迫损伤后的水肿并抑制神经胶质瘢痕的形成。 | ||||
T40004 | Pomalidomide-C7-NH2 hydrochloride
化合物Pomalidomide-C7-NH2 hydrochloride
|
2093387-55-2 | 99.36% |
|
Pomalidomide-C7-NH2 hydrochloride 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 CRBN 配体和接头。 | ||||
T40008 | Pomalidomide-C6-I TFA
化合物Pomalidomide-C6-I TFA
|
T40008 | 99.31% |
|
Pomalidomide-C6-I TFA 是一种合成的 E3 连接酶配体-接头偶联物,它结合了 PROTAC 技术中使用的基于 Pomalidomide 的 CRBN 配体和接头。 | ||||
T40003 | Thalidomide-NH-C6-NH2 hydrochloride
化合物Pomalidomide-C6-NH2 hydrochloride
|
2375194-37-7 | 99.27% |
|
Thalidomide-NH-C6-NH2 hydrochloride 包含基于 Thalidomide 的 cereblon 配体和 1 个 linker,是合成的 E3 连接酶配体-linker 偶联物,可用于 PROTAC 的合成。 |